Fact CheckerSign in

NCT05353946Recruiting

Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure

CRATER Trial: Coronary Rotational Atherectomy Elective vs. Bailout in Patients With Severely Calcified Lesions and Chronic Renal Failure

Source: ClinicalTrials.gov · Last updated 29 Apr 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The current role of the rotational atherectomy is for non-dilatable coronary lesions and for severely calcified lesions that may interfere with optimal stent expansion. Severely calcified coronary lesions are associated with worse outcomes. In this regard, chronic kidney disease is associated with severely calcified coronary arteries. Some evidence suggests that elective rotational atherectomy used by experienced operators can be safe and effective, minimizing time and complications for patients with heavily calcified lesions. However, there is no direct randomized comparison between rotational atherectomy and angioplasty alone in the setting of chronic renal failure and with intravascular ultrasound assessment for detecting severely calcified coronary arteries.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
124 (estimated)
First submitted
6 Apr 2022
Start date
2 Feb 2019
Primary completion date
27 Dec 2022
Lead sponsor
Guillermo Galeote; MD, PhD
NCT number
NCT05353946

What you commit to

  • Study type: Interventional
  • Planned participants: 124
  • From 2 Feb 2019 to the primary completion date, 27 Dec 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Acute myocardial infarction in the first 7 days of evolution.
  • Patients with allergy to iodinated contrast media

Other

  • Absence of informed consent.
  • Lesion in a single patent vessel.
  • Calcified lesions with an angulation \>60º, dissections, lesions with thrombus, and degenerated saphenous vein grafts.
  • Hemodynamically unstable patients
  • Patients with significant comorbidity and with a life expectancy of less than one year

Who the study is looking for

  • Patients \>18 years.
  • Glomerular filtration rate (GFR) \<60 mL/min/1.73 m2 for 3 months or more
  • Stenosis ≥70% in a coronary artery with a diameter ≥2,5 mm.
  • Severe angiographic calcification (affecting both sides of the arterial lumen)
  • Any clinical scenario except acute myocardial infarction in the first seven days of evolution.
  • Native coronary vessel or bypass graft.

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
La Paz University Hospital
Coordinator of this site? Confirm its status
MadridSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.